|
|
||||||||
-induced inhibition of lung morphogenesis
1 Center for Craniofacial Molecular Biology, Departments of Surgery and Pediatrics, and Cell and Developmental Biology Program, Childrens Hospital Los Angeles Research Institute, University of Southern California Schools of Dentistry and Medicine, Los Angeles, California 90033; and 2 Molecular Virology and Immunology Program, Department of Pathology and Biology, Health Science Center, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
Excessive transforming growth factor (TGF)-
signaling has been implicated in pulmonary hypoplasia associated with
bronchopulmonary dysplasia, a chronic lung disease of human prematurity
featuring pulmonary fibrosis. This implies that inhibitors of TGF-
could be useful therapeutic agents. Because exogenous TGF-
ligands are known to inhibit lung branching morphogenesis and
cytodifferentiation in mouse embryonic lungs in ex vivo culture, we
examined the capacity of a naturally occurring inhibitor of TGF-
activity, the proteoglycan decorin, to overcome the inhibitory effects
of exogenous TGF-
. Intratracheal microinjection of a recombinant
adenovirus containing decorin cDNA resulted in overexpression of the
exogenous decorin gene in airway epithelium. Although exogenous TGF-
efficiently decreased epithelial lung branching morphogenesis in
control cultures, TGF-
-induced inhibition of lung growth was
abolished after epithelial transfer of the decorin gene. Additionally,
exogenous TGF-
-induced antiproliferative effects as well as the
downregulation of surfactant protein C were abrogated by decorin in
cultured embryonic lungs. Moreover, lung branching inhibition by
TGF-
could be restored by the addition of decorin antisense
oligodeoxynucleotides in culture, indicating that decorin is both
specifically and directly involved in suppressing TGF-
-mediated
negative regulation of lung morphogenesis. Our findings suggest that
decorin can antagonize bioactive TGF-
during lung growth and
differentiation, establishing the rationale for decorin as a candidate
therapeutic approach to ameliorate excessive levels of TGF-
signaling in the developing lung.
transforming growth factor-
; intratracheal microinjection; epithelium-specific gene transfer; recombinant adenovirus; competitive
polymerase chain reaction; antisense oligodeoxynucleotide
inhibition
This article has been cited by other articles:
![]() |
B. A. Vallance, M. I. Gunawan, B. Hewlett, P. Bercik, C. Van Kampen, F. Galeazzi, P. J. Sime, J. Gauldie, and S. M. Collins TGF-{beta}1 gene transfer to the mouse colon leads to intestinal fibrosis Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G116 - G128. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Crystal, P. B. Bitterman, B. Mossman, M. I. Schwarz, D. Sheppard, L. Almasy, H. A. Chapman, S. L. Friedman, T. E. King Jr., L. A. Leinwand, et al. Future Research Directions in Idiopathic Pulmonary Fibrosis: Summary of a National Heart, Lung, and Blood Institute Working Group Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 236 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Margetts, S. Gyorffy, M. Kolb, L. Yu, C. M. Hoff, C. J. Holmes, and J. Gauldie Antiangiogenic and Antifibrotic Gene Therapy in a Chronic Infusion Model of Peritoneal Dialysis in Rats J. Am. Soc. Nephrol., March 1, 2002; 13(3): 721 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. LIU, M. SUGA, A. A. MACLEAN, J. A. ST. GEORGE, D. W. SOUZA, and S. KESHAVJEE Soluble Transforming Growth Factor-beta Type III Receptor Gene Transfection Inhibits Fibrous Airway Obliteration in a Rat Model of Bronchiolitis Obliterans Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 419 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koslowski, U. Pfeil, H. Fehrenbach, M. Kasper, E. Skutelsky, and K-W. Wenzel Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat Eur. Respir. J., August 1, 2001; 18(2): 347 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fischer, M. G. Kinsella, B. Levkau, A. W. Clowes, and T. N. Wight Retroviral Overexpression of Decorin Differentially Affects the Response of Arterial Smooth Muscle Cells to Growth Factors Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. KOLB, P. J. MARGETTS, T. GALT, P. J. SIME, Z. XING, M. SCHMIDT, and J. GAULDIE Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Wells Fibrogenesis: V. TGF-beta signaling pathways Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G845 - G850. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |